Welcome : Guest

Tetraphase Pharmaceuticals, Inc. (USA) - Facts, Figures and Analytical Insights

Abstract

This report presents quick facts about Tetraphase Pharmaceuticals, Inc., which is principally involved in Clinical-Stage Biopharmaceuticals Business. Illustrated with 12 tables, the report showcases the company's key markets and market position as against its competitors operating in the industry.

Code: PCP-65528
Price: $600
Company Type: Public
Pages: 15
Date: November 2016
Market Data Tables: 12

 NOTE : Select the checkbox below, and click Add to Cart button to add this report to your shopping cart.
Antibiotics......4
Table 1: Antibiotics Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......4
Table 2: Methicillin-Resistant Staphylococcus Aureus (MRSA) Antibiotics Market by Product Type Worldwide (2015) - Percentage Share Breakdown by Value Sales for Cubicin, Tygacil, Vancocin (Generic), Vibativ (Telavancin), and Zyvox......5
Table 3: Antibiotics Market by Category in China (2015) - Percentage Share Breakdown by Value Sales for Carbapenems, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......6
Table 4: Antibiotic Market by Drug Type in the US (2015) - Percentage Share Breakdown by Podiatrists Prescription for Cephalosporins, Macrolides, Penicillins, Quinolones, and Tetracyclines......7
Table 5: Branded Acute Bacterial Skin and Skin Structure Infection Antibiotic Market by Product Worldwide (2015) - Percentage Share Breakdown by Value for Cubicin (Daptomycin), Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......8
Table 6: Branded Community-Acquired Bacterial Pneumonia Antibiotic Market by Product Segment Worldwide (2015) - Percentage Share Breakdown by Value for Teflaro (Ceftaroline), Tygacil (Tigecycline), and Zyvox (Linezolid)......9
Infectious Disease Drugs......10
Table 7: Infectious Disease Market by Segment Worldwide (2015) - Percentage Share Breakdown by Value Sales for Molecular Diagnostics Infectious Diseases, and Others......10
Table 8: Infectious Disease Drugs Market by Category Worldwide (2015) - Percentage Share Breakdown by Value Sales for Antifungals, Antivirals, Cephalosporins, Macrolides, Penicillins, Quinolones, and Others......11
Gram Infections......12
Table 9: Gram Infection Market by Segment in European Union (2015) - Percentage Share Breakdown by Volume for Abdominal / Pelvic, Gastrointestinal/Biliary, Genitourinary, Lower Respiratory, Skin, Systemic, and Others......12
Table 10: Gram Infection Market by Segment in the US (2015) - Percentage Share Breakdown by Volume for Abdominal / Pelvic, Gastrointestinal/Biliary, Genitourinary, Lower Respiratory, Skin, Systemic, and Others......13
Impetigo Infection......14
Table 11: Impetigo Infection Market by Treatment in the US (2015) - Percentage Share Breakdown by Value for Genric Mupirocin Ointment and Others......14
Table 12: Market Shares of Leading Infectious Disease Drugs Manufacturers by Value Sales Worldwide (2014) - Percentage Breakdown for AbbVie, AstraZeneca Plc, Bristol- Myers Squibb Company, Eli Lilly and Company, F. Hoffmann-La Roche AG, Forest Laboratories, Inc., GlaxoSmithKline Plc, Johnson & Johnson, Merck Ltd., Novartis AG, Pfizer, Inc., Sanofi S.A., and Others......15